FDA Inspection 873398 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Apr 10, 2014 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 10, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville Centre, NY (United States)